Sign in
4

Changes in Ownership

IOVANCE BIOTHERAPEUTICS, INC. Filed Acc 0001104659-24-097488

Chief Operating Officer gave up 13,675 shares (to pay taxes)

  • Chief Operating Officer acquired 26,954 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

BILINSKY IGOR · Chief Operating Officer

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2024-09-03 Exercise or conversion : show line 1 in the form +3,516 44,659 D
2024-09-03 Shares withheld for taxes : show line 2 in the form −1,784 $10.85 $19,356 42,875 D
2024-09-03 Exercise or conversion : show line 3 in the form +23,438 66,313 D
2024-09-03 Shares withheld for taxes : show line 4 in the form −11,891 $10.85 $129,017 54,422 D

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2024-09-03 Exercise or conversion : show line 5 in the form Restricted Stock Units −3,516 21,097 D
2024-09-03 Exercise or conversion : show line 6 in the form Restricted Stock Units −23,438 23,437 D
Loading xslF345X05/tm2423453-2_4seq1.xml…